Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank 薬物名(臨床試験情報から抽出) KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Folic acid 1件: Folic acid5件: Acide folique; Folate; Folic Acid; Multivitamin; NICOTINAMIDE; --6件: 6, 41, 46, 49, 84, 296
2 Noradrenaline 1件: Norepinephrine2件: Norepinephrine; Norepinephrine Bitartrate; 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 22, 296
3 Vancomycin 1件: Vancomycin1件: Vancomycin; --8件: 13, 46, 70, 94, 96, 97, 296, 299
4 Acetylcysteine 1件: Acetylcysteine3件: Acetylcysteine; Mucomyst; N-acetylcysteine; --21件: 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337
5 Dexamethasone 1件: Dexamethasone5件: Decadron; Dexametasona; Dexamethasone; Dexamethasone sodium phosphate; Maxidex; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299
6 Methylprednisolone 1件: Methylprednisolone4件: Medrol; Methylprednisolon; METHYLPREDNISOLONE; Methylprednisolone acetate; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296
7 Prednisolone 1件: Prednisolone3件: Prednisolona; Prednisolone; Prednisolonum; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬42件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300
8 Pentoxifylline 1件: Pentoxifylline1件: Pentoxifylline; --12件: 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298
9 Desflurane 1件: Desflurane1件: Desflurane; --2件: 22, 296
10 Sevoflurane 1件: Sevoflurane1件: Sevoflurane; --7件: 6, 21, 22, 34, 98, 225, 296
11 Propofol 1件: Propofol2件: Propofol; Propofol Injection; 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
12 Ursodiol 1件: Ursodeoxycholic acid4件: UDCA; Ursodeoxycholic Acid; Ursodiol; Ursofalk; 1件: NR1H4 💬1件: Bile secretion 💬14件: 6, 8, 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299
13 Meloxicam 1件: Meloxicam1件: Meloxicam; 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 46, 49, 271, 296
14 Magnesium sulfate 1件: Magnesium sulfate1件: Magnesium sulfate; --3件: 11, 296, 297
15 Indocyanine green 1件: Indocyanine green1件: Indocyanine green; --8件: 22, 46, 51, 96, 235, 278, 291, 296
16 Bezafibrate 1件: Bezafibrate1件: BEZAFIBRATE; 1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬7件: 20, 93, 94, 160, 296, 316, 324
17 Icosapent ethyl 1件: Icosapent ethyl2件: Ethyl-EPA; Icosapent; --2件: 8, 296
18 Rifaximin 1件: Rifaximin3件: Rifaximin; RIFAXIMINA; Xifaxan; --9件: 6, 65, 93, 94, 96, 97, 99, 296, 299
19 Ammonia solution, strong 1件: Ammonia1件: Ammonia; --2件: 6, 296
20 Rituximab 1件: Rituximab6件: MABTHERA; Rituxan; Rituximab; Rixathon; Ruxience; TRUXIMA; 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬48件: 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
21 Belimumab 1件: Belimumab2件: Belimumab; BENLYSTA; 1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬13件: 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300
22 Filgrastim 1件: Filgrastim7件: Filgrastim; Filgrastim Hexal; G-CSF; GRANULOCYTE COLONY STIMULATING FACTOR; Neupogen; TEVAGRASTIM; Zarzio; 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬35件: 2, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331
23 Dimethyl fumarate 1件: Dimethyl fumarate3件: DIMETHYL FUMARATE; Dimethylfumarat; TECFIDERA; 1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬5件: 13, 49, 51, 86, 296
24 Lactobacillus casei 1件: Lactobacillus casei2件: Fusion; Lactobacillus casei; --10件: 6, 11, 13, 46, 49, 69, 70, 97, 271, 296
25 Magnesium gluconate 1件: Magnesium gluconate2件: Magnesium; Magnesium gluconate; --2件: 296, 297
26 Cefoperazone 1件: Cefoperazone1件: Cefoperazone; --1件: 296
27 Icosapent 1件: Icosapent2件: Eicosapentaenoic acid; Icosapent; --11件: 8, 46, 48, 49, 96, 97, 113, 296, 297, 301, 338
28 Neomycin 1件: Neomycin1件: Neomycin; --3件: 96, 97, 296
29 Propranolol 1件: Propranolol2件: Propanolol; Propranolol; 3件: ADRB1,
ADRB2,
ADRB3 💬
12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 6, 158, 167, 227, 278, 296
30 Obeticholic acid 1件: Obeticholic acid4件: 6-ECDCA; 6-ethylchenodeoxycholic acid; Obeticholic Acid; Ocaliva; 1件: NR1H4 💬1件: Bile secretion 💬3件: 93, 265, 296
31 Maralixibat 1件: Maralixibat1件: Maralixibat; 2件: SLC10A1,
SLC10A2 💬
2件: Bile secretion, Hepatitis B 💬3件: 296, 297, 338
32 Odevixibat 1件: Odevixibat1件: Odevixibat; 1件: SLC10A2 💬1件: Bile secretion 💬3件: 296, 297, 338